These results suggested that mRNA level of GBP2/3/4/6/7 plays an important role in cancer patients’ prognosis and they may be exploited as novel useful biomarkers for prediction of HNSCC patients’ survival. The gene discussed is GBP2; the disease is head and neck squamous cell carcinoma.